However, differential contribution of single NAT2 SNPs to the risk of ALL has been observed recently by Zhu et al., who performed a meta-analysis including 1,522 acute leukemia patients and 2,688 controls (11). Here, NAT2 is linked to acute lymphoblastic leukemia.